C. Marcocci

发表

Magnitude and Impact of Osteoporosis and Fractures

C. Marcocci, F. Cetani, E. Vignali, 2006 .

Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma.

C. Marcocci, A. Pinchera, P. Miccoli, 1989, Surgery.

A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancer

C. Marcocci, F. Cetani, A. Pinchera, 2004, Clinical endocrinology.

Neuropsychological assessment in schoolchildren from an area of moderate iodine deficiency

C. Marcocci, A. Pinchera, F. Santini, 1990, Journal of endocrinological investigation.

Rare diseases in clinical endocrinology: a taxonomic classification system

C. Marcocci, F. Cetani, M. Brandi, 2015, Journal of Endocrinological Investigation.

Vitamin D status and cardiovascular outcome

C. Marcocci, R. Zucchi, F. Saponaro, 2019, Journal of Endocrinological Investigation.

Hypoparathyroidism and pseudohypoparathyroidism in pregnancy: an Italian retrospective observational study

C. Marcocci, F. Cetani, M. Brandi, 2020, Orphanet Journal of Rare Diseases.

Orbital radiotherapy for Graves' ophthalmopathy.

C. Marcocci, A. Pinchera, L. Bartalena, 1998, Thyroid : official journal of the American Thyroid Association.

Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone.

C. Marcocci, A. Pinchera, L. Chiovato, 1983, The Journal of clinical endocrinology and metabolism.

Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves' ophthalmopathy.

C. Marcocci, A. Pinchera, L. Bartalena, 1987, Hormone research.

Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.

A. Gennery, C. Marcocci, F. Cetani, 2008, The Journal of clinical endocrinology and metabolism.

European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021)

L. Rejnmark, C. Marcocci, F. Cetani, 2021, European journal of endocrinology.

Intramuscular Neridronate in Postmenopausal Women with Low Bone Mineral Density

C. Marcocci, C. Fiore, S. Adami, 2008, Calcified Tissue International.

Graves’ hyperthyroidism of recent onset and Graves’ orbitopathy: To ablate or not to ablate the thyroid?

C. Marcocci, L. Bartalena, M. Tanda, 2008, Journal of endocrinological investigation.

Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease.

C. Marcocci, Y. Kohno, N. Amino, 1997, The Journal of clinical endocrinology and metabolism.

Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients’ survival

C. Marcocci, M. Scalese, A. Saba, 2017, Endocrine.

Primary hyperparathyroidism

C. Marcocci, J. Bilezikian, F. Bandeira, 2016, Nature Reviews Disease Primers.

Chapter 27 – Parathyroid Carcinoma

C. Marcocci, F. Cetani, 2015 .

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations.

C. Marcocci, F. Cetani, 2013 .

Clinical practice. Primary hyperparathyroidism.

C. Marcocci, F. Cetani, 2011, The New England journal of medicine.

Parathyroid Carcinoma

C. Marcocci, F. Cetani, A. Pinchera, 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Vitamin D measurement and effect on outcome in a cohort of patients with heart failure

C. Marcocci, F. Cetani, M. Scalese, 2018, Endocrine connections.

Definition of a population-specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS)

S. Giannini, C. Marcocci, S. Gonnelli, 2003, Osteoporosis International.

Orbital decompression for severe Graves' ophthalmopathy. Results of a three-wall operative technique.

C. Marcocci, A. Pinchera, F. Bogazzi, 1989, Journal of neurosurgical sciences.

Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism.

C. Marcocci, A. Pinchera, F. Bogazzi, 1989, The New England journal of medicine.

Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism

C. Marcocci, M. Brandi, A. Faggiano, 2015, Journal of Endocrinological Investigation.

Spontaneous short-term remission of primary hyperparathyroidism from infarction of a parathyroid adenoma

C. Marcocci, F. Cetani, A. Pinchera, 2004, Journal of endocrinological investigation.

Management of Thyrotoxicosis Induced by PD1 or PD-L1 Blockade

A. Chella, C. Marcocci, F. Santini, 2021, Journal of the Endocrine Society.

Bone fragility in patients with diabetes mellitus: A consensus statement from the working group of the Italian Diabetes Society (SID), Italian Society of Endocrinology (SIE), Italian Society of Gerontology and Geriatrics (SIGG), Italian Society of Orthopaedics and Traumatology (SIOT).

R. Marfella, C. Marcocci, F. Purrello, 2021, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Pseudohypoparathyroidism: focus on cerebral and renal calcifications.

C. Marcocci, F. Cetani, P. Piaggi, 2021, The Journal of clinical endocrinology and metabolism.

Disease activity and lifestyle influence comorbidities and cardiovascular events in patients with acromegaly.

C. Marcocci, F. Bogazzi, L. Tomisti, 2016, European journal of endocrinology.

Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO

L. Hegedüs, J. Bjorner, M. Groenvold, 2015, Quality of Life Research.

Epidemiology of primary hyperparathyroidism in Europe.

C. Marcocci, S. Adami, D. Gatti, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults.

O. Dekkers, W. van Biesen, L. Rejnmark, 2015, European journal of endocrinology.

Controversies in Vitamin D: A Statement From the Third International Conference

John H. White, R. Rizzoli, P. Lips, 2020, JBMR plus.

Controversies in Vitamin D: Summary Statement From an International Conference

C. Marcocci, C. Sempos, J. Bilezikian, 2018, The Journal of clinical endocrinology and metabolism.

Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism

R. Eastell, C. Marcocci, S. Silverberg, 2015 .

Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop.

R. Eastell, C. Marcocci, S. Silverberg, 2014, The Journal of clinical endocrinology and metabolism.

Orbital Decompression in Graves' Ophthalmopathy by Medial and Lateral Wall Removal

M. Nardi, C. Marcocci, A. Pinchera, 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Hypomagnesuria is associated with nephrolithiasis in patients with asymptomatic primary hyperparathyroidism.

C. Marcocci, F. Cetani, J. Bilezikian, 2020, The Journal of clinical endocrinology and metabolism.

Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism?

C. Marcocci, F. Cetani, M. Scalese, 2019, Journal of Endocrinological Investigation.

Subclinical vitamin D deficiency.

C. Marcocci, L. Cianferotti, 2012, Best practice & research. Clinical endocrinology & metabolism.

More on smoking habits and Graves’ ophthalmopathy

C. Marcocci, A. Pinchera, F. Bogazzi, 1989, Journal of endocrinological investigation.

OPTIC NEUROPATHY IN 2 THYROIDECTOMIZED PATIENTS WITH MODERATE TO SEVERE GRAVES OPHTHALMOPATHY FOLLOWING L-THYROXINE WITHDRAWAL PRIOR TO RADIOIODINE TREATMENT FOR THYROID CARCINOMA

M. Nardi, C. Marcocci, P. Vitti, 2015 .

Steroid treatment in the management of destructive thyrotoxicosis induced by PD1 blockade

A. Chella, C. Marcocci, F. Santini, 2022, European thyroid journal.

Current Medical Management of Thyroid Orbitopathy

C. Marcocci, A. Pinchera, L. Bartalena, 2005 .

Perspective Current Medical Management of Graves Ophthalmopathy

C. Marcocci, A. Pinchera, L. Bartalena, 2002 .

Current medical management of Graves ophthalmopathy.

C. Marcocci, A. Pinchera, L. Bartalena, 2002, Ophthalmic plastic and reconstructive surgery.

Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET

Elena S. Di Martino, N. Funel, U. Boggi, 2015, Journal of Endocrinological Investigation.

Best Practice & Research Clinical Endocrinology & Metabolism

Clinical, C. Marcocci, L. Cianferotti, 2012 .

Biochemical and ultrasound tests for early diagnosis of active neuro-osteoarthropathy (NOA) of the diabetic foot.

C. Marcocci, E. Vignali, S. Del Prato, 2002, Diabetes research and clinical practice.

First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation

C. Marcocci, F. Cetani, F. Basolo, 2014, Journal of cellular and molecular medicine.

Do the heterozygous carriers of a CYP24A1 mutation display a different biochemical phenotype than wild types?

C. Marcocci, F. Cetani, F. Baldinotti, 2020, The Journal of clinical endocrinology and metabolism.

Hypoparathyroidism and pseudohypoparathyroidism in pregnancy: an Italian retrospective observational study

C. Marcocci, F. Cetani, M. Brandi, 2020, Orphanet Journal of Rare Diseases.

Thyrotoxicosis Systemic Manifestations

C. Marcocci, F. Cetani, 2004 .

Skeletal Integrity in Men Chronically Treated with Suppressive Doses of L‐Thyroxine

C. Marcocci, E. Vignali, A. Pinchera, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Dietary calcium intake in a cohort of individuals evaluated for low bone mineral density: a multicenter Italian study

S. Giannini, C. Marcocci, G. Passeri, 2020, Aging Clinical and Experimental Research.

Dietary Calcium Intake in a Cohort of Individuals Evaluated for Low Bone Mineral Density: A Multicentre Italian Study

S. Giannini, C. Marcocci, I. Chiodini, 2020 .

Title : Dietary calcium intake in a cohort of individuals evaluated for low bone mineral density : a multicenter Italian study

S. Giannini, C. Marcocci, M. Stefano, 2020 .

Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women.

C. Marcocci, E. Vignali, A. Pinchera, 1994, The Journal of clinical endocrinology and metabolism.

Parathyroid Carcinoma and Ectopic Secretion of Parathyroid hormone.

C. Marcocci, F. Cetani, E. Pardi, 2021, Endocrinology and metabolism clinics of North America.

Whole exome sequencing in familial isolated primary hyperparathyroidism

C. Marcocci, F. Cetani, C. Mazzanti, 2020, Journal of Endocrinological Investigation.

Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors.

C. Marcocci, F. Cetani, A. Pinchera, 2004, The Journal of clinical endocrinology and metabolism.

Diagnostic, therapeutic and healthcare management protocols in parathyroid surgery: II Consensus Conference of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB)

M. Pelizzo, C. Marcocci, F. Cetani, 2014, Journal of Endocrinological Investigation.

Efficacy and safety of long-term management of patients with chronic post-surgical hypoparathyroidism

C. Marcocci, F. Cetani, E. Vignali, 2018, Journal of Endocrinological Investigation.

Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation.

C. Marcocci, A. Pinchera, P. Vitti, 2005, European journal of endocrinology.

Recent advances in the assessment of the ratios of cortisol to cortisone and of some of their metabolites in urine by LC-MS-MS.

C. Marcocci, A. Saba, A. Cupisti, 2009, Journal of mass spectrometry : JMS.

Cytokines and Thyroid Autoimmunity

C. Marcocci, A. Pinchera, L. Chiovato, 1992 .

Thyroid autoantigens and their relevance in the pathogenesis of thyroid autoimmunity.

C. Marcocci, A. Pinchera, F. Santini, 1989, Biochimie.

Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders.

C. Marcocci, A. Pinchera, L. Chiovato, 1989, Clinical immunology and immunopathology.

Long-term safety of orbital radiotherapy for Graves' ophthalmopathy.

M. Nardi, C. Marcocci, A. Pinchera, 2003, The Journal of clinical endocrinology and metabolism.

TSH suppressive therapy and bone

C. Marcocci, A. Brancatella, 2019, Endocrine connections.

Identification and characterization of circulating thyroid hormone autoantibodies in thyroid diseases, in autoimmune non thyroid illnesses and in lymphoreticular system disorders

F. Trimarchi, C. Marcocci, L. Chiovato, 1983, Journal of endocrinological investigation.

Oxidative Stress in Graves’ Disease

C. Marcocci, M. Leo, M. Altea, 2012, European Thyroid Journal.

Primary hyperparathyroidism.

C. Marcocci, F. Cetani, 1980, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Increased level of thyroglobulin mRNA in a human familial goiter

C. Marcocci, A. Pinchera, L. Chiovato, 1987, Journal of endocrinological investigation.

Sodium/proton exchange in the maintenance of intracellular pH in FRTL-5 thyroid cells.

C. Marcocci, E. Grollman, 1988, Endocrinology.

Sodium/proton exchange in FRTL-5 thyroid cells: role in the maintenance of intracellular pH and TSH-stimulated cell growth.

C. Marcocci, E. Grollman, A. Pinchera, 1987, Acta endocrinologica. Supplementum.

Effects of hormonal replacement treatment on bone mineral density and metabolism in hypogonadal patients

C. Marcocci, E. Vignali, E. Martino, 2000, Molecular and Cellular Endocrinology.

Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus

R. Rizzoli, R. Eastell, L. Rejnmark, 2016, Osteoporosis International.

Re: Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations.

C. Marcocci, F. Cetani, M. Bisceglia, 2008, Surgery.

Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism

C. Marcocci, F. Cetani, E. Vignali, 2002, Clinical endocrinology.

Development of an algorithm to predict serum vitamin D levels using a simple questionnaire based on sunlight exposure

C. Marcocci, F. Cetani, E. Vignali, 2016, Endocrine.

1,25-dihydroxyvitamin D3 specifically binds to a human breast cancer cell line (T47D) and stimulates growth.

C. Marcocci, H. Freake, I. Macintyre, 1981, Biochemical and biophysical research communications.

Vitamin D status may contribute to serum insulin-like growth factor I concentrations in healthy subjects

C. Marcocci, F. Bogazzi, L. Tomisti, 2011, Journal of endocrinological investigation.

THE 2021 EUROPEAN GROUP ON GRAVES' ORBITOPATHY (EUGOGO) CLINICAL PRACTICE GUIDELINES FOR THE MEDICAL MANAGEMENT OF GRAVES' ORBITOPATHY.

W. Wiersinga, C. Marcocci, L. Bartalena, 2021, European journal of endocrinology.

Studies on the occurrence of ophthalmopathy in Graves' disease.

C. Marcocci, A. Pinchera, F. Bogazzi, 1989, Acta endocrinologica.

CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer

M. Rugge, M. Pelizzo, M. Papotti, 2013, Endocrine connections.

Diabetes mellitus induced by somatostatin analogue therapy is not permanent in acromegalic patients

C. Marcocci, F. Bogazzi, L. Manetti, 2018, Endocrinology, diabetes & metabolism.

Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves’ ophthalmopathy treated successfully with glucocorticoids themselves

C. Marcocci, P. Vitti, E. Ambrogini, 2005, Journal of endocrinological investigation.

Case report: Early-onset osteoporosis in a patient carrying a novel heterozygous variant of the WNT1 gene

C. Marcocci, F. Cetani, A. Fogli, 2022, Frontiers in Endocrinology.

Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all?

C. Marcocci, J. Bilezikian, A. Formenti, 2021, Reviews in Endocrine and Metabolic Disorders.

Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus

L. Rejnmark, C. Marcocci, M. Brandi, 2018, European journal of endocrinology.

Management of Post-operative Hypocalcemia

C. Marcocci, 2018 .

Calcifediol Rather Than Cholecalciferol for a Patient Submitted to Malabsortive Bariatric Surgery: A Case Report

C. Marcocci, E. Vignali, D. Canale, 2017, Journal of the Endocrine Society.

Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism.

C. Marcocci, D. Shoback, J. Bollerslev, 2014, The Journal of clinical endocrinology and metabolism.

Primary Hyperparathyroidism in Men

C. Marcocci, S. Silverberg, J. Bilezikian, 2010 .

Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism

C. Marcocci, F. Cetani, E. Vignali, 2002, Journal of endocrinological investigation.

Norepinephrine and thyrotropin stimulation of iodide efflux in FRTL-5 thyroid cells involves metabolites of arachidonic acid and is associated with the iodination of thyroglobulin.

A. Luini, C. Marcocci, P. Santisteban, 1987, Endocrinology.

Effect of actinomycin D on iodide transport in FRTL-5 thyroid cells.

C. Marcocci, E. Grollman, J. Cohen, 1984, Endocrinology.

Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.

E. Brown, C. Marcocci, F. Cetani, 2000, The Journal of clinical endocrinology and metabolism.

No Evidence for Mutations in the Calcium‐Sensing Receptor Gene in Sporadic Parathyroid Adenomas

C. Marcocci, F. Cetani, E. Vignali, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone disease in primary hyperparathyrodism

C. Marcocci, F. Cetani, L. Cianferotti, 2012, Therapeutic advances in musculoskeletal disease.

[Guidelines for the diagnosis, prevention and treatment of osteoporosis].

C. Marcocci, E. Mannarino, S. Adami, 2011, Reumatismo.

Chapter 28 – Bone Turnover Markers in Primary Hyperparathyroidism

C. Marcocci, J. Bilezikian, A. G. Costa, 2015 .

Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?

C. Marcocci, F. Cetani, A. Pinchera, 2007, European journal of endocrinology.

Immune Checkpoint Blockade Anti–PD-L1 as a Trigger for Autoimmune Polyendocrine Syndrome

M. Cosottini, C. Marcocci, S. Del Prato, 2019, Journal of the Endocrine Society.

Cinacalcet in the management of primary hyperparathyroidism: post marketing experience of an Italian multicentre group

E. Papini, C. Marcocci, F. Cetani, 2013, Clinical endocrinology.

Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling

C. Marcocci, F. Cetani, E. Vignali, 2012, Journal of Endocrinological Investigation.

Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism.

L. Mosekilde, C. Marcocci, J. Nordenström, 2011, European journal of endocrinology.

Clinical presentation and management of patients with primary hyperparathyroidism in Italy

C. Marcocci, F. Cetani, M. Brandi, 2018, Journal of Endocrinological Investigation.

Occurrence of Graves’ Orbitopathy and Graves’ Hyperthyroidism after a Trauma to the Eye

C. Marcocci, P. Vitti, M. Marinò, 2017, European Thyroid Journal.

Management of Graves' ophthalmopathy: reality and perspectives.

C. Marcocci, A. Pinchera, L. Bartalena, 2000, Endocrine reviews.

Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.

M. Nardi, C. Marcocci, A. Pinchera, 2001, The Journal of clinical endocrinology and metabolism.

Cigarette Smoking and Treatment Outcomes in Graves Ophthalmopathy

M. Nardi, C. Marcocci, A. Pinchera, 1998, Annals of Internal Medicine.

Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism.

P. Chanson, C. Marcocci, J. Bilezikian, 2009, The Journal of clinical endocrinology and metabolism.

A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases.

C. Marcocci, F. Cetani, E. Vignali, 2002, European journal of endocrinology.

Thyroid directed antibodies

C. Marcocci, M. Marinò, 2005 .

Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.

M. Nardi, C. Marcocci, A. Pinchera, 1998, The New England journal of medicine.

Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands

C. Marcocci, F. Cetani, F. Basolo, 2011, Proteome Science.

Physiology of the Calcium-Parathyroid Hormone-Vitamin D Axis.

C. Marcocci, D. Goltzman, M. Mannstadt, 2018, Frontiers of hormone research.

Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial.

W. Wiersinga, C. Marcocci, L. Bartalena, 2018, The lancet. Diabetes & endocrinology.

Nonfunctioning Parathyroid Carcinoma

C. Marcocci, F. Cetani, 2016 .

Monoclonal Antibody Studies Defining the Origin and Properties of Autoantibodies in Graves' Disease

D. Corda, M. De Luca, C. Marcocci, 1986, Annals of the New York Academy of Sciences.

CHAPTER 14 – The Thyrotropin Receptor*

D. Corda, C. Marcocci, C. Rotella, 1985 .

Is the risk of primary hyperparathyroidism increased in patients with untreated breast cancer?

C. Marcocci, P. Vitti, E. Seregni, 2013, Journal of Endocrinological Investigation.

MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders.

L. Rejnmark, C. Marcocci, F. Cetani, 2019, European journal of endocrinology.

Cinacalcet in the management of primary hyperparathyroidism

C. Marcocci, F. Cetani, 2012, Expert review of endocrinology & metabolism.

Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohorts.

C. Marcocci, F. Cetani, G. Hendy, 2014, The Journal of clinical endocrinology and metabolism.

Vitamin D in the older population: a consensus statement

P. Lips, C. Marcocci, J. Bilezikian, 2022, Endocrine.

Novel Immunomodulating Agents for Graves Orbitopathy

C. Marcocci, L. Bartalena, M. Tanda, 2008, Ophthalmic plastic and reconstructive surgery.

Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases

M. Cosottini, C. Marcocci, Daniele Sgró, 2019, Endocrinology, diabetes & metabolism case reports.

Hypercalcemia due to CYP24A1 mutations: a systematic descriptive review.

C. Marcocci, F. Cetani, F. Baldinotti, 2021, European journal of endocrinology.

Treating severe Graves' ophthalmopathy.

C. Marcocci, A. Pinchera, L. Bartalena, 1997, Bailliere's clinical endocrinology and metabolism.

Radioiodine therapy and Graves' ophthalmopathy.

C. Marcocci, L. Bartalena, 2002, Thyroid : official journal of the American Thyroid Association.

Non-surgical management of primary hyperparathyroidism.

C. Marcocci, F. Cetani, F. Saponaro, 2018, Best practice & research. Clinical endocrinology & metabolism.

Update on the use of cinacalcet in the management of primary hyperparathyroidism

C. Marcocci, F. Cetani, 2011, Journal of Endocrinological Investigation.

Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database

G. Gronchi, C. Marcocci, F. Cetani, 2017, Endocrine.

Direct determination of the ratio of tetrahydrocortisol+allo-tetrahydrocortisol to tetrahydrocortisone in urine by LC-MS-MS.

C. Marcocci, E. Vignali, A. Saba, 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas

C. Marcocci, F. Cetani, N. Pellegata, 2017, Endocrine.

HRPT2 gene analysis and the diagnosis of parathyroid carcinoma

C. Marcocci, F. Cetani, E. Vignali, 2008, Expert review of endocrinology & metabolism.

GH secretion is impaired in patients with primary hyperparathyroidism.

C. Marcocci, E. Ghigo, L. Bartalena, 2002, The Journal of clinical endocrinology and metabolism.

Familial hypocalciuric hypercalcemia in a woman with metastatic breast cancer: a case report of mistaken identity.

C. Marcocci, F. Cetani, A. Pinchera, 2003, The Journal of clinical endocrinology and metabolism.

Comparison between total thyroidectomy and medical therapy for amiodarone-induced thyrotoxicosis.

C. Marcocci, F. Bogazzi, L. Tomisti, 2019, Journal of Clinical Endocrinology and Metabolism.

A patient with MEN1 and end-stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation.

U. Boggi, E. Vasile, C. Marcocci, 2017, Molecular and clinical oncology.

Primary hyperparathyroidism is associated with an impaired secretion of growth hormone but not of the other anterior pituitary hormones

C. Marcocci, L. Bartalena, M. Gasperi, 2002, Journal of endocrinological investigation.

Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy.

C. Marcocci, A. Pinchera, M. de Carli, 1993, The Journal of clinical endocrinology and metabolism.

The sulfaphenazole-sensitive pathway acts as a compensatory mechanism for impaired nitric oxide availability in patients with primary hyperparathyroidism. Effect of surgical treatment.

C. Marcocci, F. Cetani, A. Pinchera, 2010, The Journal of clinical endocrinology and metabolism.

Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves’ ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study

C. Marcocci, A. Pinchera, F. Bogazzi, 1991, Journal of endocrinological investigation.

Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features

C. Marcocci, F. Cetani, F. Bogazzi, 2017, PloS one.

Real-time PCR provides evidence for thyrotropin receptor mRNA expression in orbital as well as in extraorbital tissues.

C. Marcocci, A. Pinchera, L. Chiovato, 2002, European journal of endocrinology.

PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism

L. Rejnmark, C. Marcocci, L. Hofbauer, 2021, The Journal of clinical endocrinology and metabolism.

Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis.

M. Cosottini, C. Marcocci, F. Bogazzi, 2017, European journal of endocrinology.

Novel association of MEN1 gene mutations with parathyroid carcinoma

C. Marcocci, F. Cetani, E. Maiello, 2017, Oncology letters.

A nonfunctioning parathyroid carcinoma misdiagnosed as a follicular thyroid nodule

C. Marcocci, F. Cetani, F. Basolo, 2015, World Journal of Surgical Oncology.

Hyperparathyroidism 2 gene (HRPT2, CDC73) and parafibromin studies in two patients with primary hyperparathyroidism and uncertain pathological assessment

C. Marcocci, F. Cetani, A. Pinchera, 2008, Journal of endocrinological investigation.

Increased prevalence of primary hyperparathyroidism in treated breast cancer

C. Marcocci, E. Vignali, P. Miccoli, 2001, Journal of endocrinological investigation.

TSH-Dependent expression of the LDL receptor-associated protein (RAP) in thyroid epithelial cells.

C. Marcocci, A. Pinchera, G. Corsini, 2006, Thyroid : official journal of the American Thyroid Association.

ClC-5 does not affect megalin expression and function in the thyroid.

C. Marcocci, A. Pinchera, T. Maritzen, 2006, Thyroid : official journal of the American Thyroid Association.

Classical and Nonclassical Manifestations of Primary Hyperparathyroidism

R. Eastell, A. Mithal, C. Marcocci, 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop

G. Guyatt, C. Marcocci, S. Silverberg, 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Selenium in the Treatment of Thyroid Diseases

C. Marcocci, L. Chiovato, P. Vitti, 2017, European Thyroid Journal.

Erratum to: Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves’ orbitopathy

M. Nardi, C. Marcocci, P. Vitti, 2017, Endocrine.

Management of Mild Graves' Orbitopathy

C. Marcocci, R. Rocchi, 2017 .

Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves’ orbitopathy

M. Nardi, C. Marcocci, P. Vitti, 2016, Endocrine.

Sortilin is a putative postendocytic receptor of thyroglobulin.

C. Marcocci, A. Pinchera, A. Fausto, 2009, Endocrinology.

Management of Primary Hyperparathyroidism

G. Guyatt, L. Rejnmark, C. Marcocci, 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Comparison of radioassay and haemagglutination methods for anti-thyroid microsomal antibodies.

C. Marcocci, A. Pinchera, L. Chiovato, 1978, Clinical and experimental immunology.

Consensus statement from 2nd International Conference on Controversies in Vitamin D

C. Marcocci, A. Formenti, B. Dawson-Hughes, 2020, Reviews in Endocrine and Metabolic Disorders.

The PRIMARA study: a prospective, descriptive, observational study to review cinacalcet use in patients with primary hyperparathyroidism in clinical practice.

C. Marcocci, L. Hofbauer, J. Body, 2014, European journal of endocrinology.

Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial.

C. Marcocci, F. Cetani, E. Vignali, 2007, The Journal of clinical endocrinology and metabolism.

Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.

M. Nardi, W. Wiersinga, C. Marcocci, 2008, European journal of endocrinology.

Association of the changes in cytosolic Ca2+ and iodide efflux induced by thyrotropin and by the stimulation of alpha 1-adrenergic receptors in cultured rat thyroid cells.

A. Luini, D. Corda, C. Marcocci, 1985, The Journal of biological chemistry.

A rapid screening of a recurrent CYP24A1 pathogenic variant opens the way to molecular testing for Idiopathic Infantile Hypercalcemia (IIH).

G. Gambaro, C. Marcocci, E. Capoluongo, 2018, Clinica chimica acta; international journal of clinical chemistry.

Calcium-sensing receptor gene polymorphism is not associated with bone mineral density in Italian postmenopausal women.

C. Marcocci, F. Cetani, E. Vignali, 2003, European journal of endocrinology.

Chapter 37 – Medical Management of Primary Hyperparathyroidism

C. Marcocci, Aliya A. Khan, 2015 .

Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the CYP24A1 Gene: A Case Report and Review of the Literature

C. Marcocci, F. Cetani, E. Vignali, 2019, Case reports in endocrinology.

A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis.

C. Marcocci, F. Cetani, A. Pinchera, 2001, The Journal of clinical endocrinology and metabolism.

Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association.

C. Marcocci, L. Bartalena, J. Orgiazzi, 2012, European journal of endocrinology.

Cutaneous metastasis of a radiation-associated thyroid medullary carcinoma

C. Marcocci, G. Bevilacqua, S. Mariotti, 1984, Journal of endocrinological investigation.

Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism.

C. Marcocci, F. Cetani, E. Vignali, 2009, The Journal of clinical endocrinology and metabolism.

Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism.

A Pinchera, C. Marcocci, F. Cetani, 1991, The Journal of clinical endocrinology and metabolism.

Graves’ disease and Turner’s syndrome

Elena S. Di Martino, C. Marcocci, A. Pinchera, 1980, Journal of endocrinological investigation.

Expanding the phenotype of 22q11 deletion syndrome: the MURCS association

C. Marcocci, A. Renieri, F. Mari, 2008, Clinical dysmorphology.

L-Thyroxine therapy induces a fall of thyroid microsomal and thyroglobulin antibodies in idiopathic myxedema and in hypothyroid, but not in euthyroid Hashimoto’s thyroiditis

C. Marcocci, A. Pinchera, L. Chiovato, 1986, Journal of endocrinological investigation.

Changes of circulating thyroid autoantibody levels during and after therapy with methimazole in patients with Graves’ disease

C. Marcocci, A. Pinchera, L. Chiovato, 1982, Journal of endocrinological investigation.

Preferential megalin-mediated transcytosis of low-hormonogenic thyroglobulin: A control mechanism for thyroid hormone release

Samuel Refetoff, Paolo Vitti, Michele Marino, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy.

M. Nardi, C. Marcocci, P. Vitti, 2017, Thyroid : official journal of the American Thyroid Association.

Thyrotoxicosis, Overview of Causes

C. Marcocci, R. Rocchi, 2004 .

Late-onset postsurgical hypoparathyroidism following parathyroidectomy for recurrent primary hyperparathyroidism: a case report and literature review

C. Marcocci, F. Cetani, E. Pardi, 2020, Endocrine.

A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves’ hyperthyroidism

C. Marcocci, G. Fenzi, C. Ceccarelli, 1990, Journal of endocrinological investigation.

Endoscopic parathyroidectomy: report of an initial experience.

C. Marcocci, E. Vignali, A. Pinchera, 1998, Surgery.

Minimally invasive surgery for thyroid small nodules: Preliminary report

C. Marcocci, P. Miccoli, P. Berti, 1999, Journal of endocrinological investigation.

Impaired GH secretion to provocative stimuli in two families with hypocalciuric hypercalcaemia

C. Marcocci, F. Cetani, A. Pinchera, 2003, Clinical endocrinology.

Growth hormone secretion in primary and secondary hyperparathyroidism

C. Marcocci, A. Pinchera, F. Bogazzi, 2005, Journal of endocrinological investigation.

Improvement of growth hormone deficiency in patients with primary hyperparathyroidism after parathyroidectomy: results of a prospective study.

C. Marcocci, A. Pinchera, F. Bogazzi, 2004, The Journal of clinical endocrinology and metabolism.

High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study.

M. Nardi, C. Marcocci, P. Vitti, 2018, Thyroid : official journal of the American Thyroid Association.

Effects of treatment modalities for Graves’ hyperthyroidism on Graves’ orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement

P. Macchia, C. Marcocci, L. Bartalena, 2015, Journal of Endocrinological Investigation.

Circulating microRNAs as biomarkers of osteoporosis and fragility fractures.

C. Marcocci, M. Brandi, F. Giusti, 2022, The Journal of clinical endocrinology and metabolism.

PCB153 reduces apoptosis in primary cultures of murine pituitary cells through the activation of NF-κB mediated by PI3K/Akt

C. Marcocci, F. Bogazzi, F. Raggi, 2020, Molecular and Cellular Endocrinology.

Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues

C. Marcocci, E. Vignali, P. Miccoli, 1998, Journal of endocrinological investigation.

Genetic profiling of orbital fibroblasts from patients with Graves' orbitopathy.

M. Nardi, C. Marcocci, F. Basolo, 2021, The Journal of clinical endocrinology and metabolism.

Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors?

C. Marcocci, Y. Hayashi, R. Weiss, 1995, The Journal of clinical endocrinology and metabolism.

A proteomic approach to study parathyroid glands.

C. Marcocci, F. Cetani, A. Pinchera, 2010, Molecular bioSystems.

Update on parathyroid carcinoma

C. Marcocci, F. Cetani, E. Pardi, 2016, Journal of Endocrinological Investigation.

Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management

C. Marcocci, F. Cetani, E. Vignali, 2006, Clinical endocrinology.

Teprotumumab for the Treatment of Active Thyroid Eye Disease.

Terry J. Smith, R. Holt, C. Marcocci, 2020, The New England journal of medicine.

Selenium and the course of mild Graves' orbitopathy.

M. Nardi, M. Prummel, W. Wiersinga, 2011, The New England journal of medicine.

A severe inactivating PTH/PTHrP signaling disorder type 2 in a patient carrying a novel large deletion of the GNAS gene: a case report and review of the literature

C. Marcocci, F. Cetani, S. Borsari, 2020, Endocrine.

Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors.

C. Marcocci, F. Cetani, L. Torregrossa, 2019, Endocrine-related cancer.

Divergent Effects of Dioxin- or Non-Dioxin-Like Polychlorinated Biphenyls on the Apoptosis of Primary Cell Culture from the Mouse Pituitary Gland

C. Marcocci, F. Bogazzi, L. Tomisti, 2016, PloS one.

Teprotumumab Efficacy, Safety and Durability in Longer Duration Thyroid Eye Disease and Retreatment: Optic-X Study.

Terry J. Smith, R. Holt, C. Marcocci, 2021, Ophthalmology.

Thyroid autoimmunity and thyroid autonomy.

C. Marcocci, A. Pinchera, L. Chiovato, 1990, Acta medica Austriaca.

Demonstration and organ distribution of the 1,25-dihydroxyvitamin D3-binding protein in fish (A. anguilla).

C. Marcocci, H. Freake, I. Macintyre, 1982, Endocrinology.

Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions

John H. White, P. Lips, C. Marcocci, 2018, Endocrine reviews.

Preoperative localization of suspicious parathyroid adenomas by assay of parathyroid hormone in needle aspirates.

C. Marcocci, E. Vignali, A. Pinchera, 1998, European journal of endocrinology.

AME position statement: primary hyperparathyroidism in clinical practice.

C. Marcocci, R. Guglielmi, D. Rao, 2012, Journal of endocrinological investigation.

Studies on thyroid cell surface antigens using cultured human thyroid cells.

C. Marcocci, A. Pinchera, L. Chiovato, 1982, Clinical and experimental immunology.

A Case of Unilateral Dermopathy Possibly Related to Graves’ Disease

C. Marcocci, P. Vitti, F. Basolo, 2019, European Thyroid Journal.

Role of the underlying thyroid disease on the phenotype of Graves' orbitopathy in a tertiary referral center.

M. Nardi, C. Marcocci, P. Vitti, 2015, Thyroid : official journal of the American Thyroid Association.

Thyroid volume and severity of Graves' orbitopathy.

M. Nardi, C. Marcocci, A. Pinchera, 2013, Thyroid : official journal of the American Thyroid Association.

Outcome of Graves' orbitopathy after total thyroid ablation and glucocorticoid treatment: follow-up of a randomized clinical trial.

M. Nardi, C. Marcocci, A. Pinchera, 2012, The Journal of clinical endocrinology and metabolism.

Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids.

M. Nardi, C. Marcocci, A. Pinchera, 2007, The Journal of clinical endocrinology and metabolism.

Glycosaminoglycans provide a binding site for thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy.

C. Marcocci, A. Pinchera, L. Chiovato, 2003, Thyroid : official journal of the American Thyroid Association.

Therapeutic controversies. Radioiodine may be bad for Graves' ophthalmopathy, but....

C. Marcocci, A. Pinchera, L. Bartalena, 1995, The Journal of clinical endocrinology and metabolism.

Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.

C. Marcocci, A. Pinchera, F. Bogazzi, 1992, Thyroid : official journal of the American Thyroid Association.

Endoscopic parathyroidectomy by a gasless approach.

C. Marcocci, A. Pinchera, P. Miccoli, 1998, Journal of laparoendoscopic & advanced surgical techniques. Part A.

High-intensity focused ultrasound as an alternative to the surgical approach in primary hyperparathyroidism: A preliminary experience

C. Marcocci, F. Cetani, P. Miccoli, 2011, Journal of endocrinological investigation.

Video-assisted versus conventional parathyroidectomy in primary hyperparathyroidism: a prospective randomized study.

C. Marcocci, E. Vignali, A. Pinchera, 1999, Surgery.

Comparison among sonography, double-tracer subtraction scintigraphy, and double-phase scintigraphy in the detection of parathyroid lesions.

C. Bartolozzi, D. Caramella, R. Lencioni, 1996, AJR. American journal of roentgenology.

Multidetector CT in diagnostic work-up of patients with primary hyperparathyroidism

C. Bartolozzi, D. Caramella, C. Marcocci, 2007, La radiologia medica.

Contrast-enhanced color doppler ultrasonography in suspected parathyroid lesions

C. Bartolozzi, D. Caramella, C. Marcocci, 2000, Acta radiologica.

Usefulness of echo-color Doppler in differentiating parathyroid lesions from other cervical masses

C. Bartolozzi, D. Caramella, R. Lencioni, 2014, European Radiology.

Unmet therapeutic, educational and scientific needs in parathyroid disorders: Consensus Statement from the first European Society of Endocrinology Workshop (PARAT)

L. Rejnmark, C. Marcocci, F. Cetani, 2019, European Journal of Endocrinology.

Diagnosis and classification of Graves' disease.

C. Marcocci, F. Menconi, M. Marinò, 2014, Autoimmunity reviews.

The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy

W. Wiersinga, C. Marcocci, L. Bartalena, 2016, European Thyroid Journal.

Identification and functional characterization of loss-of-function mutations of the calcium-sensing receptor in four Italian kindreds with familial hypocalciuric hypercalcemia.

E. Brown, C. Marcocci, F. Cetani, 2009, European journal of endocrinology.

Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience.

M. Nardi, W. Wiersinga, C. Marcocci, 2003, European journal of endocrinology.

Clinical features of dysthyroid optic neuropathy: a European Group on Graves’ Orbitopathy (EUGOGO) survey

Michele Marinò, M. Nardi, M. Prummel, 2006, British Journal of Ophthalmology.

PREGO (presentation of Graves’ orbitopathy) study: changes in referral patterns to European Group On Graves’ Orbitopathy (EUGOGO) centres over the period from 2000 to 2012

L. Hegedüs, M. Nardi, W. Wiersinga, 2015, British Journal of Ophthalmology.

Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study.

C. Marcocci, P. Vitti, M. Brunetto, 2015, European journal of endocrinology.

Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy

M. Nardi, C. Marcocci, P. Vitti, 2018, JAMA ophthalmology.

Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease

C. Marcocci, M. Marinò, G. Lanzolla, 2021, Frontiers in Endocrinology.

Antioxidant Therapy in Graves’ Orbitopathy

C. Marcocci, M. Marinò, G. Lanzolla, 2020, Frontiers in Endocrinology.

Oxidative Stress in Graves Disease and Graves Orbitopathy

C. Marcocci, M. Marinò, G. Lanzolla, 2020, European Thyroid Journal.

Mechanistic Pathways of Selenium in the Treatment of Graves’ Disease and Graves’ Orbitopathy

C. Marcocci, M. Marinò, M. Leo, 2018, Hormone and Metabolic Research.

Oxidative stress and Graves’ hyperthyroidism

C. Marcocci, M. Marinò, M. Leo, 2018 .

Spontaneous improvement of untreated mild Graves' ophthalmopathy: Rundle's curve revisited.

M. Nardi, C. Marcocci, P. Vitti, 2014, Thyroid : official journal of the American Thyroid Association.

Role of oxidative stress and selenium in Graves' hyperthyroidism and orbitopathy.

C. Marcocci, L. Bartalena, 2013, Journal of endocrinological investigation.

Treatment of mild, moderate-to-severe and very severe Graves' orbitopathy.

C. Marcocci, M. Marinò, 2012, Best practice & research. Clinical endocrinology & metabolism.

Somatostatin analogs for Graves' ophthalmopathy: do they bounce off like a rubber bullet?

C. Marcocci, A. Pinchera, L. Bartalena, 2004, The Journal of clinical endocrinology and metabolism.

Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy.

M. Nardi, W. Wiersinga, C. Marcocci, 2008, Thyroid : official journal of the American Thyroid Association.

Orbital radiotherapy for Graves' ophthalmopathy.

C. Marcocci, A. Pinchera, G. Barbesino, 2002, Thyroid : official journal of the American Thyroid Association.

Glucocorticoid administration for Graves’ hyperthyroidism treated by radioiodine. A questionnaire survey among members of the European Thyroid Association

W. Wiersinga, C. Marcocci, L. Bartalena, 2010 .

Treatment options for Graves' orbitopathy

C. Marcocci, M. Leo, M. Altea, 2012, Expert opinion on pharmacotherapy.

ORBITAL COBALT IRRADIATION COMBINED WITH RETROBULBAR OR SYSTEMIC CORTICOSTEROIDS FOR GRAVES' OPHTHALMOPATHY: A COMPARATIVE STUDY

C. Marcocci, A. Pinchera, L. Bartalena, 1987, Clinical endocrinology.

Epidemiology, pathogenesis of primary hyperparathyroidism: Current data.

C. Marcocci, F. Saponaro, 2015, Annales d'endocrinologie.

Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss‐of‐function mutations in the calcium‐sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation

C. Marcocci, F. Cetani, A. Pinchera, 2003, Clinical endocrinology.

Orbital radiotherapy for Graves’ ophthalmopathy: Useful or useless? Safe or dangerous?

W. Wiersinga, C. Marcocci, A. Pinchera, 2003, Journal of endocrinological investigation.

MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism

C. Marcocci, F. Cetani, E. Vignali, 2002, Journal of endocrinological investigation.

A novel germline mutation of MEN 1 gene in a patient with acromegaly and multiple endocrine tumors

C. Carcassi, C. Marcocci, F. Cetani, 2004, Journal of endocrinological investigation.

Six novel MEN1 gene mutations in sporadic parathyroid tumors

C. Marcocci, F. Cetani, E. Vignali, 2000 .

A new mutation of the MEN1 gene in an italian kindred with multiple endocrine neoplasia type 1.

C. Marcocci, F. Cetani, E. Vignali, 1999, European journal of endocrinology.

A new mutation of the MEN 1 gene in an Italian kindred with multiple endocrine neoplasia type 1

C. Marcocci, F. Cetani, E. Vignali, 1999 .

Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy.

M. Prummel, W. Wiersinga, C. Marcocci, 1995, The Journal of clinical endocrinology and metabolism.

Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.

C. Marcocci, F. Cetani, F. Basolo, 2013, The Journal of clinical endocrinology and metabolism.

Parathyroid Carcinoma and Adenoma Co-existing in One Patient: Case Report and Comparative Proteomic Analysis

C. Marcocci, F. Cetani, F. Ciregia, 2021, Cancer Genomics & Proteomics.

Selenium usage and oxidative stress in Graves’ disease and Graves’ orbitopathy

C. Marcocci, M. Marinò, G. Lanzolla, 2020 .

Selenium in Graves Hyperthyroidism and Orbitopathy.

C. Marcocci, F. Menconi, M. Marinò, 2018, Ophthalmic plastic and reconstructive surgery.

A 2016 Italian Survey about the Clinical Use of Selenium in Thyroid Disease

E. Papini, R. Negro, C. Marcocci, 2016, European Thyroid Journal.

Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation.

C. Marcocci, F. Cetani, A. Pinchera, 2007, Endocrine-related cancer.

Activating Antibodies to Calcium-Sensing Receptor In Immunotherapy-Induced Hypoparathyroidism.

C. Marcocci, F. Cetani, E. Kemp, 2020, The Journal of clinical endocrinology and metabolism.

Does Graves’ Orbitopathy Ever Disappear Answers to an Old Question

M. Nardi, C. Marcocci, P. Vitti, 2017, European Thyroid Journal.

Cigarette Smoking and Thyroid Eye Disease

C. Marcocci, A. Pinchera, L. Bartalena, 2002 .

Management of thyroid eye disease

C. Marcocci, A. Pinchera, L. Bartalena, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

Immunosuppressive management of Graves’ ophthalmopathy

M. Prummel, W. Wiersinga, C. Marcocci, 2000 .

Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas.

C. Marcocci, F. Cetani, A. Pinchera, 2010, Endocrine-related cancer.

Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis

M. Lucchi, C. Marcocci, S. Mariotti, 2020, European Thyroid Journal.

Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis

C. Marcocci, E. Vignali, R. Guglielmi, 2016, Journal of Endocrinological Investigation.

Solubilization of human thyroid microsomal antigen.

C. Marcocci, A. Pinchera, L. Chiovato, 1979, The Journal of clinical endocrinology and metabolism.

Concomitant Primary Hyperparathyroidism in Patients with Multiple Myeloma: A Possible Link?

C. Marcocci, F. Cetani, N. Giuliani, 2020, Acta Haematologica.

Microvessel density in human normal and neoplastic parathyroids

C. Marcocci, F. Cetani, G. Bevilacqua, 2006, Endocrine pathology.

Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26‐Week Results From the Phase 3 PaTHway Trial

C. Sibley, L. Rejnmark, C. Marcocci, 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4

C. Marcocci, F. Cetani, N. Pellegata, 2014, Endocrine connections.

Parafibromin as a tool for the diagnosis of parathyroid tumors.

C. Marcocci, F. Cetani, 2008, Advances in anatomic pathology.

Do patients with atypical parathyroid adenoma need a close follow-up?

C. Marcocci, F. Cetani, F. Basolo, 2021, The Journal of clinical endocrinology and metabolism.

Circulating Long Non-Coding RNA GAS5 Is Overexpressed in Serum from Osteoporotic Patients and Is Associated with Increased Risk of Bone Fragility

C. Marcocci, M. Brandi, G. Novelli, 2020, International journal of molecular sciences.

Measurement of urinary free cortisol by LC–MS–MS: adoption of a literature reference range and comparison with our current immunometric method

C. Marcocci, P. Vitti, P. Agretti, 2019, Journal of Endocrinological Investigation.

Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST.

G. Brabant, C. Marcocci, A. Pinchera, 1990, The Journal of clinical endocrinology and metabolism.

Soluble interleukin‐1 receptor antagonist concentration in patients with Graves' ophthalmopathy is neither related to cigarette smoking nor predictive of subsequent response to glucocorticoids

C. Marcocci, A. Pinchera, G. Barbesino, 2000, Clinical endocrinology.

HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy

A. Gaspari, F. Trimarchi, G. Perigli, 2018, Calcified Tissue International.

Graves’ Disease Induced by Immune Checkpoint Inhibitors: A Case Report and Review of the Literature

C. Marcocci, P. Vitti, S. Brogioni, 2019, European Thyroid Journal.

Management of Thyrotoxicosis Induced by PD1 or PD-L1 Blockade

A. Chella, C. Marcocci, F. Santini, 2021, Journal of the Endocrine Society.

Multiple genetic factors in the heterogeneity of thyroid hormone resistance.

C. Marcocci, R. Weiss, S. Refetoff, 1993, The Journal of clinical endocrinology and metabolism.

Parathyroid carcinoma: a clinical and genetic perspective.

C. Marcocci, F. Cetani, E. Pardi, 2018, Minerva endocrinologica.

Measurement of 1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and clinical indices.

D. Easton, R. Coombes, C. Marcocci, 1984, Cancer research.

SIMULTANEOUS ASSAY OF THYROID ADENYLATE CYCLASE‐ AND GROWTH‐STIMULATING ANTIBODIES USING FRTL‐5 CELLS. EVIDENCE SUGGESTING THEIR IDENTITY IN PATIENTS WITH GRAVES' DISEASE

C. Marcocci, A. Pinchera, F. Santini, 1989, Clinical endocrinology.

TSH-Blocking Antibodies and Congenital Hypothyroidism

C. Marcocci, A. Pinchera, F. Santini, 1989 .

Iodine and Autoimmune Thyroid Disease

C. Marcocci, A. Pinchera, L. Chiovato, 1990 .

Thyroid hypoechogenic pattern at ultrasonography as a tool for predicting recurrence of hyperthyroidism after medical treatment in patients with Graves' disease.

L Chiovato, M Tonacchera, A Pinchera, 1992, Acta endocrinologica.

Ablative or non-ablative therapy for Graves’ hyperthyroidism in patients with ophthalmopathy?

C. Marcocci, A. Pinchera, L. Bartalena, 1998, Journal of endocrinological investigation.

Monoclonal antibodies as probes of thyrotropin receptor structure

C. Marcocci, M. Luca, P. Laccetti, 1984 .

NEW PROCEDURES FOR DETECTING GRAVES' IMMUNOGLOBULINS

C. Marcocci, C. Rotella, E. Grollman, 1985 .

Graves’ IgG stimulation of iodide uptake in FRTL-5 rat thyroid cells: A clinical assay complementing FRTL-5 assays measuring adenylate cyclase and growth-stimulating antibodies in autoimmune thyroid disease

C. Marcocci, E. Grollman, L. Kohn, 1983, Journal of endocrinological investigation.

Graves' ophthalmopathy: a preventable disease?

C. Marcocci, A. Pinchera, L. Bartalena, 2002, European journal of endocrinology.

VARIABLES AFFECTING THE LONG-TERM OUTCOME OF GRAVES ORBITOPATHY FOLLOWING HIGH-DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY.

M. Nardi, C. Marcocci, P. Vitti, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

The reduction of bone mineral density in postmenopausal women with primary hyperparathyroidism is higher in the presence of concomitant GH secretion impairment.

C. Marcocci, F. Cetani, F. Bogazzi, 2006, European journal of endocrinology.

Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy.

C. Marcocci, P. Vitti, M. Brunetto, 2015, Thyroid : official journal of the American Thyroid Association.

Radioiodine and thyroid-associated ophthalmopathy

C. Marcocci, A. Pinchera, F. Bogazzi, 1996 .

GRAVES' OPHTHALMOPATHY: THE ROLE OF THYROID CROSS REACTING AUTOANTIGENS AND THE EFFECT OF THYROID ABLATION

C. Marcocci, A. Pinchera, F. Latrofa, 2006 .

Novel aspects of immunosuppressive and radiotherapy management of Graves’ ophthalmopathy

C. Marcocci, F. Menconi, M. Marinò, 2004, Journal of endocrinological investigation.

Novel approaches to the management of graves' ophthalmopathy.

C. Marcocci, A. Pinchera, L. Bartalena, 2002, Hormones.

Thyroid management in Graves' ophthalmopathy

M. Prummel, W. Wiersinga, C. Marcocci, 2000 .

HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy

A. Gaspari, F. Trimarchi, G. Perigli, 2018, Calcified Tissue International.

Clinical approach to goitre.

C. Marcocci, A. Pinchera, F. Aghini‐Lombardi, 1988, Bailliere's clinical endocrinology and metabolism.

Management of Graves’ hyperthyroidism and orbitopathy in time of COVID-19 pandemic

C. Marcocci, L. Chiovato, P. Vitti, 2020, Journal of Endocrinological Investigation.

Autoantibodies Stimulating Thyroid Growth and Adenylate Cyclase Cannot be Separated in IgGs From Patients with Active Graves’ Disease

C. Marcocci, A. Pinchera, L. Chiovato, 1987 .

TSH Receptor Autoantibodies Affecting Thyroid Cell Function

C. Marcocci, L. Chiovato, P. Vitti, 1987 .

Studies on the mechanism responsible for thyrotropin-induced expression of microsomal/peroxidase antigen in FRTL-5 cells.

C. Marcocci, A. Pinchera, L. Chiovato, 1988, Endocrinology.

A treatment strategy for Graves' orbitopathy

C. Marcocci, A. Pinchera, M. Marinò, 2007, Nature Clinical Practice Endocrinology &Metabolism.

Role of the adenylate cyclase-cAMP system on TSH-stimulated thyroid cell growth.

C. Marcocci, G. Fenzi, E. Grollman, 1987, Acta endocrinologica. Supplementum.

SCREENING FOR RISK OF DELIVERY OF A HYPOTHYROID BABY

C. Marcocci, A. Pinchera, L. Chiovato, 1986, The Lancet.

Familial and Hereditary Forms of Primary Hyperparathyroidism.

C. Marcocci, F. Cetani, S. Borsari, 2018, Frontiers of hormone research.

Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database

C. Marcocci, F. Cetani, M. Brandi, 2018, Endocrine.

Clinical profile of juvenile primary hyperparathyroidism: a prospective study

C. Marcocci, F. Cetani, M. Miccoli, 2018, Endocrine.

Persistent secondary hyperparathyroidism and vertebral fractures in kidney transplantation: Role of calcium‐sensing receptor polymorphisms and vitamin D deficiency

S. Giannini, L. Bonfante, A. D'Angelo, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism

C. Marcocci, F. Cetani, E. Vignali, 2016, Endocrine.

Role of the cholesterol biosynthetic pathway in osteoblastic differentiation.

C. Marcocci, E. Vignali, G. Viccica, 2007, Journal of endocrinological investigation.

Minimally invasive, video-assisted parathyroid surgery for primary hyperparathyroidism

C. Marcocci, E. Vignali, A. Pinchera, 1997, Journal of endocrinological investigation.

Treatment of Graves’ Ophthalmopathy by Retrobulbar Corticosteroids Associated With Orbital Cobalt Radiotherapy

C. Marcocci, A. Pinchera, L. Bartalena, 1987 .

Presentation of Graves’ orbitopathy within European Group On Graves’ Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III)

C. Marcocci, G. Kahaly, D. Führer, 2023, The British journal of ophthalmology.

Natural history of graves’ orbitopathy after treatment

M. Nardi, C. Marcocci, P. Vitti, 2017, Endocrine.

Nutrition and Supplements in Thyroid Eye Disease

C. Marcocci, F. Menconi, 2015 .

Selenium and Graves’ Orbitopathy

C. Marcocci, F. Menconi, M. Altea, 2014 .

Identification and characterization of a novel de novo mutation (L346V) in the thyroid hormone receptor beta gene in a family with generalized thyroid hormone resistance.

C. Marcocci, A. Pinchera, E. Martino, 1997, European journal of endocrinology.

Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline.

C. Marcocci, G. Clines, G. Fuleihan, 2022, The Journal of clinical endocrinology and metabolism.

The parathyroids : basic and clinical concepts

R. Marcus, C. Marcocci, S. Silverberg, 1994 .

An update on medical management of Graves’ ophthalmopathy

C. Marcocci, A. Pinchera, L. Bartalena, 2005, Journal of endocrinological investigation.

Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial.

M. Nardi, C. Marcocci, P. Piaggi, 2021, The lancet. Diabetes & endocrinology.

Challenges in the Preoperative Localization of Hyperfunctioning Parathyroid Tissue in a Patient with Primary Hyperparathyroidism

C. Marcocci, F. Cetani, M. Apicella, 2022, A Case-Based Guide to Clinical Endocrinology.

Rehabilitative orbital decompression for Graves' orbitopathy: risk factors influencing the new onset of diplopia in primary gaze, outcome, and patients' satisfaction.

M. Nardi, C. Marcocci, A. Pinchera, 2012, Thyroid : official journal of the American Thyroid Association.

Orbital radiotherapy for Graves' ophthalmopathy.

C. Marcocci, A. Pinchera, L. Bartalena, 2004, Journal of Clinical Endocrinology and Metabolism.

The use of positron emission tomography with 11C-methionine in patients with primary hyperparathyroidism

C. Marcocci, F. Cetani, 2013, Endocrine.

Cytokine antagonists: new ideas for the management of Graves' ophthalmopathy.

C. Marcocci, A. Pinchera, L. Bartalena, 1996, The Journal of clinical endocrinology and metabolism.

Graves' ophthalmopathy: reality and perspectives

C. Marcocci, A. Pinchera, L. Bartalena, 2000 .

Reasons for revision surgery after orbital decompression for Graves’ orbitopathy

M. Nardi, C. Marcocci, A. Pinchera, 2008, Clinical ophthalmology.

Orbital radiotherapy in the treatment of endocrine ophthalmopathy: when and why?

C. Marcocci, A. Pinchera, F. Bogazzi, 1993, Developments in ophthalmology.

The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis

C. Marcocci, F. Bogazzi, L. Tomisti, 2016, Journal of Endocrinological Investigation.

Statins: a new hope on the horizon of Graves' Orbitopathy?

C. Marcocci, M. Marinò, G. Lanzolla, 2021, The Journal of clinical endocrinology and metabolism.

A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (Aip) gene in an Italian family with gigantism

C. Marcocci, F. Bogazzi, L. Tomisti, 2014, Journal of Endocrinological Investigation.

Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome

C. Marcocci, F. Cetani, F. Bogazzi, 2023, Frontiers in endocrinology.

Long-term efficacy and safety of rifampin in the treatment of a patient carrying a CYP24A1 loss-of-function variant.

C. Marcocci, F. Cetani, F. Baldinotti, 2022, The Journal of clinical endocrinology and metabolism.

Controversial issues in climacteric medicine IV Postmenopausal osteoporosis: therapeutic options

C. Christiansen, C. Campagnoli, J. Kanis, 2005 .

Effects of selenium on short-term control of hyperthyroidism due to Graves’ disease treated with methimazole: results of a randomized clinical trial

C. Marcocci, P. Vitti, L. Bartalena, 2017, Journal of Endocrinological Investigation.

Acute severe primary hyperparathyroidism: spontaneous remission after 2 years follow-up

C. Marcocci, F. Cetani, F. Ferrari, 2018, Journal of Endocrinological Investigation.

Acute pancreatitis as the first manifestation in a young boy with primary hyperparathyroidism

C. Marcocci, F. Cetani, Sara Barone, 2018, Endocrine.

Parathyroid Carcinoma.

C. Marcocci, F. Cetani, E. Pardi, 2018, Frontiers of Hormone Research.

Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study.

S. Giannini, C. Marcocci, F. Cetani, 2021, Panminerva medica.

The impact of thyroidectomy on parathyroid glands: A biochemical and clinical profile

C. Marcocci, F. Cetani, E. Vignali, 2007, Journal of endocrinological investigation.

Sirolimus as a second-line treatment for Graves’ orbitopathy

C. Marcocci, P. Piaggi, F. Menconi, 2022, Journal of Endocrinological Investigation.

Surgical complications in orbital decompression for Graves' orbitopathy

M. Nardi, C. Marcocci, I. Dallan, 2016, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.

Gene expression profile in metastatic and non-metastatic parathyroid carcinoma.

C. Marcocci, F. Cetani, P. Graziano, 2020, Endocrine-related cancer.

Normocalcemic primary hyperparathyroidism: a survey in a small village of Southern Italy

C. Marcocci, F. Cetani, E. Vignali, 2015, Endocrine connections.

Familial hypocalciuric hypercalcemia type 1 due to a novel homozygous mutation of the calcium-sensing receptor gene

C. Marcocci, F. Cetani, S. Borsari, 2017, Journal of Endocrinological Investigation.

Incidental occurrence of metastatic medullary thyroid carcinoma in a patient with multiple endocrine neoplasia type 1 carrying germline MEN1 and somatic RET mutations

C. Marcocci, F. Cetani, R. Elisei, 2017, Journal of surgical oncology.

Six novel MEN1 gene mutations in sporadic parathyroid tumors.

C. Marcocci, F. Cetani, E. Vignali, 2000, Human Mutation.

Is parathyroidectomy beneficial in patients with mild, asymptomatic primary hyperparathyroidism?

C. Marcocci, A. Pinchera, 2007, Nature Clinical Practice Endocrinology &Metabolism.

Spontaneous improvement of untreated mild Graves' ophthalmopathy: Rundle's curve revisited.

M. Nardi, C. Marcocci, P. Vitti, 2014, Thyroid : official journal of the American Thyroid Association.

Recent advances in the assessment of the ratios of cortisol to cortisone and of some of their metabolites in urine by LC-MS-MS.

C. Marcocci, A. Saba, A. Cupisti, 2009, Journal of Mass Spectrometry.

Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers.

M. Nardi, M. Prummel, W. Wiersinga, 2006, European journal of endocrinology.

Rehabilitative orbital decompression for Graves’ orbitopathy: risk factors influencing the new onset of diplopia in primary gaze, outcome and patients’ satisfaction. A large retrospective study.

M. Nardi, C. Marcocci, A. Pinchera, 2012 .

Outcome of orbital decompression for disfiguring proptosis in patients with Graves’ orbitopathy using various surgical procedures

M. Nardi, W. Wiersinga, C. Marcocci, 2008, British Journal of Ophthalmology.

Approach to the Patient With Parathyroid Carcinoma.

C. Marcocci, F. Cetani, L. Torregrossa, 2023, The Journal of clinical endocrinology and metabolism.

Rehabilitative orbital decompression for Graves’ orbitopathy: results of a randomized clinical trial

C. Marcocci, P. Vitti, I. Dallan, 2018, Journal of Endocrinological Investigation.

NEW INSIGHTS INTO PTH AND CALCIUM RECEPTOR SIGNALING Is Urinary Calcium the Only Predictor of Nephrolithiasis in Patients with Asymptomatic Primary Hyperparathyroidism?

C. Marcocci, S. Borsari, F. Saponaro, 2020 .